Download PDF
Kardiologie up2date 2012; 08(03): 233-252
DOI: 10.1055/s-0032-1310277
Diagnostische Verfahren und Bildgebung
© Georg Thieme Verlag KG Stuttgart · New York

Nicht invasive kardiologische Bildgebung bei Herzinsuffizienz

Henning Steen
,
Florian André
Further Information

Publication History

Publication Date:
09 October 2012 (online)

Also available at
    Permissions and Reprints All articles of this category

Abstract

Heart failure is the fastest growing cardiac diagnosis in Europe with an incidence of 10 cases per 1000 people in individuals older than 65. The vital role of cardiac imaging in the management of patients with heart failure continues to grow. As many novel imaging markers emerge, it becomes difficult for clinicians to choose the imaging tests that can best aid clinical decisions for a given patient. Echocardiography remains a first-line test in heart failure and continues to provide valuable information on left ventricular and valvular function. Single-photon emission computed tomography (SPECT) is routinely used to detect ischemia. However, there is increasing evidence to support the use of other imaging modalities, cardiovascular magnetic resonance (CMR), positron emission tomography (PET) and computed tomography (CT), to assist heart failure physicians with clinical decision making. In this review, we summarize the most recent developments relevant to heart failure.

Kernaussagen

  • Die Herzinsuffizienz zeigt in den westlichen Industrienationen eine stark zunehmende Prävalenz und eine Inzidenz von annähernd 10 Patienten pro 1000 Individuen, die älter als 65 Lebensjahre sind.

  • Die Therapie der HIS ist zunehmend komplexer und bedarf der genauen Indikationsstellung und des exakten Monitorings. Dieses Monitoring gelingt zunehmend mit sog. Biomarkern, also charakteristisch und objektiv messbaren Indikatoren biologischer und pathologischer Prozesse. Hier erfüllt neben den serologischen Biomarkern wie z. B. ANP, BNP oder NT-pro BNP die moderne Bildgebung eine wichtige Rolle, in dem sie eine große Anzahl neuer morphologischer und funktioneller Marker bietet, die mittels verschiedener Bildgebungsverfahren dargestellt und gemessen werden können.

  • Im Rahmen der klinischen HIS haben sich hierbei im Wesentlichen die Echokardiografie und das Kardio-MRT als sinnvoll erwiesen, wobei beide Verfahren aufgrund ihrer unterschiedlichen Vor- und Nachteile durchaus als komplementär anzusehen sind. Die höhere zeitliche Auflösung der Echokardiografie machen diese Technik besonders wertvoll in der Bestimmung der diastolischen Funktionsstörung, während die höhere räumliche Auflösung und die Möglichkeit der Anwendung unterschiedlicher MRT-Sequenzen (T1-, T2-Wichtung, Mapping, LGE) das Kardio-MRT besonders für die Beurteilung der systolischen Funktion, der Morphologie und der Gewebecharakterisierung empfehlen. Obwohl die Kardio-MRT nur begrenzt zugänglich und kosten- und personalintensiv ist, kompliziert in der Anwendung erscheint und Kontraindikationen wie Herzschrittmacher und Defibrillatoren bedacht werden müssen, ist sie doch eine wertvolle Alternative und Ergänzung zur Echokardiografie.

 

  • Literatur

  • 1 Hogg K, Swedberg K, McMurray J. Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol 2004; 43: 317-327
    CrossrefPubMedGoogle Scholar
  • 2 Senni M, Redfield MM. Heart failure with preserved systolic function. A different natural history?. J Am Coll Cardiol 2001; 38: 1277-1282
    CrossrefPubMedGoogle Scholar
  • 3 Gandhi SK, Powers JC, Nomeir AM et al. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med 2001; 344: 17-22
    CrossrefPubMedGoogle Scholar
  • 4 Cleland JG, Swedberg K, Follath F et al. The EuroHeart Failure survey programme – a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 2003; 24: 442-463
    PubMedGoogle Scholar
  • 5 Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart 2007; 93: 1137-1146
    CrossrefPubMedGoogle Scholar
  • 6 McMurray JJ. Clinical practice. Systolic heart failure. N Engl J Med 2010; 362: 228-238
    CrossrefPubMedGoogle Scholar
  • 7 Haider AW, Larson MG, Benjamin EJ et al. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol 1998; 32: 1454-1459
    CrossrefPubMedGoogle Scholar
  • 8 Mor-Avi V, Sugeng L, Weinert L et al. Fast measurement of left ventricular mass with real-time three-dimensional echocardiography: comparison with magnetic resonance imaging. Circulation 2004; 110: 1814-1818
    CrossrefPubMedGoogle Scholar
  • 9 Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613-618
    CrossrefPubMedGoogle Scholar
  • 10 Steen H, Nasir K, Flynn E et al. Is magnetic resonance imaging the ‘reference standard’ for cardiac functional assessment? Factors influencing measurement of left ventricular mass and volumes.. Clin Res Cardiol 2007; 96: 743-751
    CrossrefPubMedGoogle Scholar
  • 11 Lang RM, Bierig M, Devereux RB et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006; 7: 79-108
    CrossrefPubMedGoogle Scholar
  • 12 Sugeng L, Mor-Avi V, Weinert L et al. Quantitative assessment of left ventricular size and function: side-by-side comparison of real-time three-dimensional echocardiography and computed tomography with magnetic resonance reference. Circulation 2006; 114: 654-661
    CrossrefPubMedGoogle Scholar
  • 13 Tighe DA, Rosetti M, Vinch CS et al. Influence of image quality on the accuracy of real time three-dimensional echocardiography to measure left ventricular volumes in unselected patients: a comparison with gated-SPECT imaging. Echocardiography 2007; 24: 1073-1080
    CrossrefPubMedGoogle Scholar
  • 14 Jenkins C, Moir S, Chan J et al. Left ventricular volume measurement with echocardiography: a comparison of left ventricular opacification, three-dimensional echocardiography, or both with magnetic resonance imaging. Eur Heart J 2009; 30: 98-106
    CrossrefPubMedGoogle Scholar
  • 15 Ruan Q, Nagueh SF. Usefulness of isovolumic and systolic ejection signals by tissue Doppler for the assessment of left ventricular systolic function in ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2006; 97: 872-875
    CrossrefPubMedGoogle Scholar
  • 16 Gjesdal O, Hopp E, Vartdal T et al. Global longitudinal strain measured by two-dimensional speckle tracking echocardiography is closely related to myocardial infarct size in chronic ischaemic heart disease. Clin Sci (Lond) 2007; 113: 287-296
    CrossrefPubMedGoogle Scholar
  • 17 Zerhouni EA, Parish DM, Rogers WJ et al. Human heart: tagging with MR imaging – a method for noninvasive assessment of myocardial motion. Radiology 1988; 169: 59-63
    PubMedGoogle Scholar
  • 18 Osman NF. Detecting stiff masses using strain-encoded (SENC) imaging. Magn Reson Med 2003; 49: 605-608
    CrossrefPubMedGoogle Scholar
  • 19 Hennig J, Schneider B, Peschl S et al. Analysis of myocardial motion based on velocity measurements with a black blood prepared segmented gradient-echo sequence: methodology and applications to normal volunteers and patients. J Magn Reson Imaging 1998; 8: 868-877
    CrossrefPubMedGoogle Scholar
  • 20 Bess RL, Khan S, Rosman HS et al. Technical aspects of diastology: why mitral inflow and tissue Doppler imaging are the preferred parameters?. Echocardiography 2006; 23: 332-339
    Google Scholar
  • 21 Nagueh SF, Appleton CP, Gillebert TC et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009; 22: 107-133
    CrossrefPubMedGoogle Scholar
  • 22 Leong DP, De Pasquale CG, Selvanayagam JB. Heart failure with normal ejection fraction: the complementary roles of echocardiography and CMR imaging. JACC Cardiovasc Imaging 2010; 3: 409-420
    CrossrefPubMedGoogle Scholar
  • 23 Hillis GS, Moller JE, Pellikka PA et al. Noninvasive estimation of left ventricular filling pressure by E/e' is a powerful predictor of survival after acute myocardial infarction. J Am Coll Cardiol 2004; 43: 360-367
    CrossrefPubMedGoogle Scholar
  • 24 Rubinshtein R, Glockner JF, Feng D et al. Comparison of magnetic resonance imaging versus Doppler echocardiography for the evaluation of left ventricular diastolic function in patients with cardiac amyloidosis. Am J Cardiol 2009; 103: 718-723
    CrossrefPubMedGoogle Scholar
  • 25 Petersen SE, Jung BA, Wiesmann F et al. Myocardial tissue phase mapping with cine phase-contrast mr imaging: regional wall motion analysis in healthy volunteers. Radiology 2006; 238: 816-826
    CrossrefPubMedGoogle Scholar
  • 26 Nagel E, Stuber M, Burkhard B et al. Cardiac rotation and relaxation in patients with aortic valve stenosis. Eur Heart J 2000; 21: 582-589
    CrossrefPubMedGoogle Scholar
  • 27 Edvardsen T, Rosen BD, Pan L et al. Regional diastolic dysfunction in individuals with left ventricular hypertrophy measured by tagged magnetic resonance imaging – the Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J 2006; 151: 109-114
    CrossrefPubMedGoogle Scholar
  • 28 Korosoglou G, Youssef AA, Bilchick KC et al. Real-time fast strain-encoded magnetic resonance imaging to evaluate regional myocardial function at 3.0 Tesla: comparison to conventional tagging. J Magn Reson Imaging 2008; 27: 1012-1018
    CrossrefPubMedGoogle Scholar
  • 29 Neizel M, Lossnitzer D, Korosoglou G et al. Strain-encoded MRI for evaluation of left ventricular function and transmurality in acute myocardial infarction. Circ Cardiovasc Imaging 2009; 2: 116-122
    CrossrefPubMedGoogle Scholar
  • 30 McCrohon JA, Moon JC, Prasad SK et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003; 108: 54-59
    CrossrefPubMedGoogle Scholar
  • 31 Choudhury L, Mahrholdt H, Wagner A et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2002; 40: 2156-2164
    CrossrefPubMedGoogle Scholar
  • 32 Moon JC, Sachdev B, Elkington AG et al. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J 2003; 24: 2151-2155
    CrossrefPubMedGoogle Scholar
  • 33 Maceira AM, Joshi J, Prasad SK et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005; 111: 186-193
    CrossrefPubMedGoogle Scholar
  • 34 Anderson LJ, Holden S, Davis B et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001; 22: 2171-2179
    CrossrefPubMedGoogle Scholar
  • 35 Kim RJ, Wu E, Rafael A et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343: 1445-1453
    CrossrefPubMedGoogle Scholar
  • 36 Candell-Riera J et al. Prognostic value of myocardial perfusion-gated SPECT in patients with ischemic cardiomyopathy. J Nucl Cardiol 2009; 16: 212-221
    CrossrefPubMedGoogle Scholar
  • 37 Yu M et al. The next generation of cardiac positron emission tomography imaging agents: discovery of flurpiridaz F-18 for detection of coronary disease. Semin Nucl Med 2011; 41: 305-313
    PubMedGoogle Scholar
  • 38 Beanlands RS et al. CCS/CAR/CANM/CNCS/CanSCMR joint position statement on advanced noninvasive cardiac imaging using positron emission tomography, magnetic resonance imaging and multidetector computed tomographic angiography in the diagnosis and evaluation of ischemic heart disease – executive summary. Can J Cardiol 2007; 23: 107-119
    CrossrefPubMedGoogle Scholar
  • 39 Schinkel AF et al. Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol 2007; 32 (07) 375-410
    CrossrefPubMedGoogle Scholar
  • 40 Maffei E et al. Diagnostic accuracy of 64-slice computed tomography coronary angiography in a large population of patients without revascularisation: registry data and review of multicentre trials. Radiol Med 2010; 115: 368-384
    CrossrefPubMedGoogle Scholar
  • 41 Ghostine S et al. Non-invasive diagnosis of ischaemic heart failure using 64-slice computed tomography. Eur Heart J 2008; 29 (17) 2133-2140
    CrossrefPubMedGoogle Scholar